Clinical Trial: Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT06723080) titled 'Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis' on Dec. 05.

Brief Summary: This clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study

Study Start Date: Dec. 30

Study Type: INTERVENTIONAL

Condition: Moderate to Severe Atopic Dermatitis

Intervention: DRUG: VC005 low dose group

VC005 low dose group repeat administration

DRUG: VC005 high dose group

VC005 high dose group repeat administration

DRUG: VC005 Placebo group

VC005 Placebo group repeat administration

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu vcare pharmaceut...